James Simsarian
- Pathology and Forensic Medicine top 10%
- Rheumatology top 10%
- Immunology
- Oncology
- Neurology
- Co-authors
- Gavin GiovannoniGabriel PardoBettina StubinskiPer Soelberg SørensenО. Л. БарбарашCarol SaundersLuanne M. MetzJohn King
- Topics
- Multiple Sclerosis Research Studies (8 papers)Viral Infections and Immunology Research (3 papers)Immunodeficiency and Autoimmune Disorders (2 papers)
- Partner nations
- United StatesUnited KingdomRussia
In The Last Decade
James Simsarian
12 papers receiving 291 citations
Peers
Comparison fields: 5 of 65
- Pathology and Forensic Medicine 185
- Rheumatology 87
- Immunology 68
- Oncology 62
- Neurology 59
Countries citing papers authored by James Simsarian
This map shows the geographic impact of James Simsarian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Simsarian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Simsarian more than expected).
Fields of papers citing papers by James Simsarian
This network shows the impact of papers produced by James Simsarian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Simsarian. The network helps show where James Simsarian may publish in the future.
Co-authorship network of co-authors of James Simsarian
This figure shows the co-authorship network connecting the top 25 collaborators of James Simsarian. A scholar is included among the top collaborators of James Simsarian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Simsarian. James Simsarian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 27 | |
| 2 | 27 | |
| 3 | Safety and immunogenicity of a new formulation of interferon beta-1a (Rebif (R) new formulation) in a phase IIIb study in patients with relapsing multiple sclerosis: 96-week results | 38 |
| 4 | Immunogenicity of Rebif (R) New Formulation (interferon beta-1a) in patients with relapsing multiple sclerosis: results from a phase IIIb study | 3 |
| 5 | 54 | |
| 6 | 11 | |
| 7 | 30 | |
| 8 | 34 | |
| 9 | 1 | |
| 10 | 57 | |
| 11 | 32 | |
| 12 | 1 | |
| 13 | 1 |
About James Simsarian
James Simsarian is a scholar working on Pathology and Forensic Medicine, Sensory Systems and Immunology, having authored 13 papers that have together received 316 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (8 papers), Viral Infections and Immunology Research (3 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (185 citations), Rheumatology (87 citations) and Neurology (59 citations). James Simsarian has collaborated with scholars based in United States, United Kingdom and Russia. Frequent co-authors include Gavin Giovannoni, Gabriel Pardo, Bettina Stubinski, Per Soelberg Sørensen, О. Л. Барбараш, Carol Saunders, Luanne M. Metz, John King, Michelle Smith and John L. Decker. Their work appears in journals such as Multiple Sclerosis Journal, Clinical Therapeutics and Value in Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.